Medicare Part D coverage · dimethyl fumarate · RxCUI 1373491
dimethyl fumarate 240 MG Delayed Release Oral Capsule
Per the CMS 2026 Part D formulary file, dimethyl fumarate 240 MG Delayed Release Oral Capsule is covered by 3,697 Medicare Part D plans (73.2% of enrollable products), averaging Tier 3.5, with prior authorization required on 76.2% of covering formularies.
- 73.2%
- Plan coverage
- 3,697
- Plans covering
- T3.5
- Avg tier
- 76.2%
- Prior auth required
What the CMS Formulary Data Shows for dimethyl fumarate 240 MG Delayed Release Oral Capsule
Per the CMS 2026 Part D formulary file, dimethyl fumarate 240 MG Delayed Release Oral Capsule (RxNorm concept RXCUI 1373491, generic name dimethyl fumarate) appears on 265 distinct formulary files spanning 3,697 Medicare Part D plan offerings - 73.2% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.5.
Real-world access to dimethyl fumarate 240 MG Delayed Release Oral Capsule depends on utilization management as much as tier placement: 76.2% of covering formularies require prior authorization. 0% require step therapy. 95.5% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 7,901 Part D beneficiaries filled dimethyl fumarate 240 MG Delayed Release Oral Capsule in 2023, with total plan-and-beneficiary spending of $104,119,392 and an average per-beneficiary annual cost of $13,178.00. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry dimethyl fumarate 240 MG Delayed Release Oral Capsule today.
Coverage Details
- Formularies covering
- 265
- Plans covering
- 3,697
- Coverage rate
- 73.2%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 76.2% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 95.5% of formularies
2023 Medicare Spending
- Beneficiaries
- 7,901
- Total spending
- $104,119,392
- Avg per beneficiary
- $13,178.00
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering dimethyl fumarate 240 MG Delayed Release Oral Capsule
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Sentara Community Complete Select (HMO D-SNP) | Sentara Health Plans | T1 | Yes | $0 | VA |
| Sentara Community Complete (HMO D-SNP) | Sentara Health Plans | T1 | Yes | $0 | VA |
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | Yes | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | Yes | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | Yes | $0 | NJ |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | Yes | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | Yes | $0 | GA |
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | Yes | $0 | MI |
| PruittHealth Premier D-SNP (HMO D-SNP) | Pruitthealth Premier, Inc. | T1 | No | $0 | GA |
| Simpra Advantage Dual Care (PPO D-SNP) | Simpra Advantage, Inc. | T1 | No | $0 | AL |
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T1 | Yes | $0 | CA |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | Yes | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Horizon NJ TotalCare (HMO D-SNP) | Horizon Healthcare OF NEW Jersey, Inc. | T1 | Yes | $0 | NJ |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | Yes | $0 | MN |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | Yes | $0 | MA |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $0 | NY |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
Show the next 30 plans
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| Elevate Medicare Choice (HMO D-SNP) | Denver Health Medical Plan, Inc. | T1 | Yes | $0 | CO |
| AllCare Advantage Redwood Rx (HMO D-SNP) | Allcare Health Plan, Inc. | T1 | Yes | $0 | OR |
| PrimeWest Senior Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | Yes | $0 | MN |
| Prime Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | Yes | $0 | MN |
| Alterwood Advantage Dual Secure (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | Yes | $0 | MD |
| Nascentia Dual Advantage (HMO D-SNP) | Visiting Nurse Association OF Central NEW York | T1 | Yes | $0 | NY |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | Yes | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | Yes | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | Yes | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | Yes | $0 | MO |
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | Yes | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | Yes | $0 | AR |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| FHCP Medicare Classic (HMO) | Florida Blue Medicare, Inc. | T1 | Yes | $0 | FL |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T1 | Yes | $0 | CA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | Yes | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | Yes | $0 | DE |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is dimethyl fumarate 240 MG Delayed Release Oral Capsule covered by Medicare Part D?
Yes, dimethyl fumarate 240 MG Delayed Release Oral Capsule is covered by 3,697 Medicare Part D plans (73.2% of all Part D formularies).
What tier is dimethyl fumarate 240 MG Delayed Release Oral Capsule on Medicare Part D plans?
dimethyl fumarate 240 MG Delayed Release Oral Capsule averages Tier 3.5 across Part D plans, ranging from Tier 1 to Tier 5.
Does dimethyl fumarate 240 MG Delayed Release Oral Capsule require prior authorization?
76.2% of Part D formularies require prior authorization for dimethyl fumarate 240 MG Delayed Release Oral Capsule. Step therapy: 0%. Quantity limits: 95.5%.
How much does Medicare spend on dimethyl fumarate 240 MG Delayed Release Oral Capsule?
In 2023, total Medicare Part D spending on dimethyl fumarate 240 MG Delayed Release Oral Capsule was $104,119,392, covering 7,901 beneficiaries. The average spend per beneficiary was $13,178.00.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- lomustine 10 MG Oral Capsule [Gleostine] T3.5
- 24 HR tacrolimus 0.75 MG Extended Release Oral Tablet [Envarsus] T3.5
- triamterene 50 MG Oral Capsule T3.5
- {1 (ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG / sodium ascorbate 48110 MG / sodium chloride 3200 MG Powder for Oral Solution) / 1 (polyethylene glycol 3350 100000 MG / potassium chloride 1000 MG / sodium chloride 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution) } Pack [Plenvu] T3.5
- naftifine hydrochloride 10 MG/ML Topical Cream T3.5
- {2 (480 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack [Suprep Bowel Prep Kit] T3.5
Similar prior-authorization rate
- bedaquiline 100 MG Oral Tablet [Sirturo] 76.2% PA
- bedaquiline 20 MG Oral Tablet [Sirturo] 76.1% PA
- letermovir 120 MG Oral Pellet [Prevymis] 76.5% PA
- 1 ML filgrastim-aafi 0.3 MG/ML Injection [Nivestym] 76.6% PA
- 1.6 ML filgrastim-aafi 0.3 MG/ML Injection [Nivestym] 76.6% PA
- vigabatrin 500 MG Powder for Oral Solution [Vigadrone] 75.8% PA